<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of microbiology, epidemiology and immunobiology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of microbiology, epidemiology and immunobiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Журнал микробиологии, эпидемиологии и иммунобиологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0372-9311</issn><issn publication-format="electronic">2686-7613</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">13947</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">COMPARATIVE CHARACTERISTICS OF HLA SYSTEM GENE DISTRIBUTION IN PATIENTS WITH LUNG TUBERCULOSIS OF THE RUSSIAN POPULATION OF CHELYABINSK REGION</article-title><trans-title-group xml:lang="ru"><trans-title>СРАВНИТЕЛЬНАЯ ХАРАКТЕРИСТИКА РАСПРЕДЕЛЕНИЯ ГЕНОВ СИСТЕМЫ HLA У БОЛЬНЫХ ТУБЕРКУЛЕЗОМ ЛЕГКИХ РУССКОЙ ПОПУЛЯЦИИ ЧЕЛЯБИНСКОЙ ОБЛАСТИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Burmistrova</surname><given-names>A. L</given-names></name><name xml:lang="ru"><surname>Бурмистрова</surname><given-names>А. Л</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belyaeva</surname><given-names>S. V</given-names></name><name xml:lang="ru"><surname>Беляева</surname><given-names>С. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Suslova</surname><given-names>T. A</given-names></name><name xml:lang="ru"><surname>Суслова</surname><given-names>Т. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bukharin</surname><given-names>O. V</given-names></name><name xml:lang="ru"><surname>Бухарин</surname><given-names>О. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Chelyabinsk State University</institution></aff><aff><institution xml:lang="ru">Челябинский государственный университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Chelyabinsk Hemotransfusion Station</institution></aff><aff><institution xml:lang="ru">Челябинская станция переливания крови</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Research Institute of Cellular and Intracellular Symbiosis</institution></aff><aff><institution xml:lang="ru">Институт клеточного и внутриклеточного симбиоза</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2014</year></pub-date><volume>91</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2014)</issue-title><issue-title xml:lang="ru">№3 (2014)</issue-title><fpage>35</fpage><lpage>41</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Burmistrova A.L., Belyaeva S.V., Suslova T.A., Bukharin O.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Бурмистрова А.Л., Беляева С.В., Суслова Т.А., Бухарин О.В.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Burmistrova A.L., Belyaeva S.V., Suslova T.A., Bukharin O.V.</copyright-holder><copyright-holder xml:lang="ru">Бурмистрова А.Л., Беляева С.В., Суслова Т.А., Бухарин О.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://microbiol.crie.ru/jour/article/view/13947">https://microbiol.crie.ru/jour/article/view/13947</self-uri><abstract xml:lang="en"><p>Aim. Study of distribution of genes and HLA system haplotypes A, B, DRB1, DQA1, DQB1 in healthy individuals and patients with lung tuberculosis, members ofthe Russian population of Chelyabinsk region for isolation of risk markers for the development of various forms of tuberculosis. Materials and methods. The study group consisted of 86 patients with lung tuberculosis of the Tuberculosis Dispensary No. 3 of Chelyabinsk of Russian nationality. 239 healthy donors of Chelyabinsk Hemotransfusion Station of Russian nationality composed the comparison group. HLA-typing was carried out by multiprimer polymerase chain reaction - PCR SSP, HLA II genotyping - by DNA technology (Russia) kits, HLA class I - by methods described in the article by Downing J.M.G. et al. (2004). Result detection was carried out by electrophoresis. Results. In lung tuberculosis patients high frequency of detection of HLA haplotype DRB1*16-DQA1*01:02-DQB1*05:02/4 was established. In patients with fibrous-cavernous form В*08 and DRB1*03 gene frequency ofdetection increased and DRB1*07 and DQA1*02:01 genes did not occur. During focal form high frequency of HLA В*15 and HLA DRB1*15 alleles was determined compared with infiltrative form. HLA A*01-B*08-DRB1*03-DQA1*05:01-DQB1*02:01 haplotype only occurred in groups of patients with more severe forms of tuberculosis. Conclusion. Markers of sensitivity to clinical phenotypes of tuberculosis were isolated.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Изучение распределения генов и гаплотипов системы HLA A, B, DRB1, DQA1, DQB1 у здоровых лиц и больных туберкулезом легких представителей русской популяции Челябинской области для выделения маркеров риска развития различных клинических форм туберкулеза. Материалы и методы. Исследуемую группу составили 86 пациентов, больных туберкулезом легких Противотуберкулезного диспансера №3 г. Челябинск русской национальности. Группу сравнения составили 239 здоровых доноров Челябинской областной станции переливания крови русской национальности. HLA-типирование проводили методом мульти-праймерной полимеразной цепной реакции - PCR SSP, генотипирование HLA II - наборами НПФ «ДНК-технология» («ДНК-технология», Россия) HLA I класса по методикам, описанным в статье Downing J.M.G. et al. (2004). Детекцию результатов проводили методом электрофореза. Результаты. У больных туберкулезом легких установлена высокая частота встречаемости гаплотипа HLA DRB1*16-DQA1*01:02-DQB1*05:02/4. У больных с фиброзно-кавернозной формой повышена частота встречаемости генов В*08 и DRB1*03, и не встречались гены DRB1*07 и DQA1*02:01. При очаговой форме определена высокая частота аллелей HLA В*15 и HLA DRB1*15 по сравнению с инфильтративной формой. Гаплотип HLA A*01-B*08-DRB1*03-DQA1*05:01-DQB1*02:01 встречался только в группах больных с более тяжелыми формами туберкулеза. Заключение. Выделены маркеры чувствительности к клиническим фенотипам туберкулеза.</p></trans-abstract><kwd-group xml:lang="en"><kwd>HLA</kwd><kwd>HLA</kwd><kwd>lung tuberculosis</kwd><kwd>haplotype</kwd><kwd>host-microbiota</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>туберкулез легких</kwd><kwd>гаплотип</kwd><kwd>хозяин-микробиота</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Бурмистрова А.Л. Иммунный гомеостаз и микросимбиоценоз. Метаморфозы и пути развития воспалительных заболеваний кишечника. Челябинск, Челябинский дом печати, 1997.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бухарин О.В., Лобакова Е.С., Перунова Н.Б., Усвяцов Б.Я., Черкасов С.В. Симбиоз и его роль в инфекции. Екатеринбург, УрО РАН, 2011.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Кондакова М.Н., Павлова М.В. Современные принципы лечения туберкулеза органов дыхания у подростков. Педиатрия. 2010, 89 (4): 58-62.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Тимофеева С.В., Суслова ТА., Вавилов М.Н., Ананьева И.П. Полиморфизм HLA А у больных туберкулезом легких представителей русской этнической группы Челябинской области. Вестник гематологии. 2009, 5 (4): 57-58.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Тимофеева С.В., Сташкевич Д.С., Суслова ТА., Ананьева И.П. Распределение двухлокусных гаплотипов HLA-DRB1-TNFA(-308) у больных туберкулезом легких. Вестник Уральской медицинской академической науки. 2012, 4 (41): 247-248.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Blaser M.J., Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature. 2007, 449 (7164): 843-849.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 2009, 7 (12): 887-894.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Caws M., Thwaites G., Dunstan S. et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4 (3): 1-9.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Downing J.M.G., Guttridge J. et al. Five-Locus HLA typing of hematopoietic stem cell donor volunteers using PCR sequence specific primers. Genetic Testing. 2004, 8 (3): 301-312.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Falkow S. Is persistent bacterial infection good for your health? Cell. 2006, 124 (4): 699-702.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gagneux S., DeRiemer K., Van T. et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 2006, 103 (8): 2869-2873.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gutierrez M.C., Brisse S., Brosch R. et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS. 2005, 1 (1): 0055-0061.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jermy A. Bacterial physiology: no rest for the persisters. Nat. Rev. Microbiol. 2013, 11 (3):148.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kettaneh A., Seng L., Tiev K.P. et al. Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int. J. Tuberc. Lung. Disease. 2006, 10 (7): 717-725.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lio D. A. G., Candore A. Colombo et al. genetically determined high setting of TNF-a influences immunologic parameters of HLA-B8,dr3 positive subjects: implications for autoimmunity. Human Immunology. 2001, 62: 705-713.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Maertzdorf J., Repsilber D., Parida S.K. et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 2011, 12 (1): 15-22.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Pareek M., Evans J., Innes J. et al. Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax. 2013, 68 (3): 221-229.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Roca F. J., Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell. 2013, 153: 521-534.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Rook G.A. 99th dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the «hygiene» or «old friends» hypothesis. Clin. Exp. Immunol. 2010, 160 (1): 70-79.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schuijt T.J., van der Poll T., de Vos WM., Wiersinga WJ. The intestinal microbiota and host immune interactions in the critically ill. Trends Microbiol. 2013, 21 (5): 221-229.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Turnbaugh P.J., Gordon J.I. An invitation to the marriage ofmetagenomics and metabolomics. Cell. 2008, 134 (5): 708-713.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Vannberg F.O., Chapman S.J., Hill A.V Human genetic susceptibility to intracellular pathogens. Immunol. Rev. 2011, 240 (1): 105-116.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Walzl G., Ronacher K., Hanekom W Immunological biomarkers oftuberculosis. Nat. Rev. Immunol. 2011, 11 (5): 43-54.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Young D., Stark J., Kirschner D. et al. Infection: tuberculosis as a case study. Nat. Rev. Microbiol. 2008, 6 (7): 520-528.</mixed-citation></ref></ref-list></back></article>
